Prestige Consumer Healthcare Inc. (NYSE:PBH) to Post Q3 2023 Earnings of $1.01 Per Share, William Blair Forecasts

Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating) – Analysts at William Blair reduced their Q3 2023 earnings estimates for shares of Prestige Consumer Healthcare in a research note issued to investors on Thursday, November 3rd. William Blair analyst J. Andersen now forecasts that the company will post earnings per share of $1.01 for the quarter, down from their previous estimate of $1.04. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.20 per share.

Prestige Consumer Healthcare (NYSE:PBHGet Rating) last posted its quarterly earnings data on Thursday, August 4th. The company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.06. Prestige Consumer Healthcare had a net margin of 18.83% and a return on equity of 12.88%. The company had revenue of $277.06 million for the quarter, compared to analysts’ expectations of $268.19 million.

A number of other equities research analysts have also weighed in on PBH. Oppenheimer lowered their price objective on shares of Prestige Consumer Healthcare to $63.00 in a report on Thursday, September 29th. StockNews.com initiated coverage on Prestige Consumer Healthcare in a research report on Wednesday, October 12th. They issued a “buy” rating on the stock. Finally, DA Davidson reissued a “neutral” rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, August 9th.

Prestige Consumer Healthcare Price Performance

PBH opened at $55.49 on Monday. The stock has a 50-day moving average price of $51.65 and a 200-day moving average price of $54.91. The stock has a market capitalization of $2.76 billion, a P/E ratio of 13.47, a PEG ratio of 1.63 and a beta of 0.55. Prestige Consumer Healthcare has a 12-month low of $48.51 and a 12-month high of $63.83. The company has a current ratio of 2.21, a quick ratio of 1.23 and a debt-to-equity ratio of 0.89.

Institutional Investors Weigh In On Prestige Consumer Healthcare

Several hedge funds have recently modified their holdings of PBH. Meeder Asset Management Inc. increased its holdings in shares of Prestige Consumer Healthcare by 79.0% during the second quarter. Meeder Asset Management Inc. now owns 451 shares of the company’s stock valued at $27,000 after purchasing an additional 199 shares during the period. Global Retirement Partners LLC raised its holdings in shares of Prestige Consumer Healthcare by 3,435.7% in the 3rd quarter. Global Retirement Partners LLC now owns 495 shares of the company’s stock worth $27,000 after buying an additional 481 shares in the last quarter. Lindbrook Capital LLC lifted its position in Prestige Consumer Healthcare by 3,000.0% during the 2nd quarter. Lindbrook Capital LLC now owns 496 shares of the company’s stock worth $29,000 after buying an additional 480 shares in the last quarter. Ronald Blue Trust Inc. boosted its stake in Prestige Consumer Healthcare by 349.3% in the third quarter. Ronald Blue Trust Inc. now owns 602 shares of the company’s stock valued at $36,000 after acquiring an additional 468 shares during the last quarter. Finally, Eagle Bay Advisors LLC grew its holdings in shares of Prestige Consumer Healthcare by 163.7% in the 2nd quarter. Eagle Bay Advisors LLC now owns 1,287 shares of the company’s stock valued at $76,000 after buying an additional 799 shares during the period. 99.37% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Company Profile

(Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

See Also

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.